Degarelix for treating advanced hormone‐sensitive prostate cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of degarelix compared with standard systemic androgen suppression therapy (in the form of surgical castration, medical castration using GnRH agonists, non‐steroidal or steroidal antiandrogen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Jakob, Joachim J, Schmidt, Stefanie, Kunath, Frank, Meerpohl, Joerg J, Blümle, Anette, Schmucker, Christine, Mayer, Benjamin, Zengerling, Friedemann
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2017
Teme:
Medicine General & Introductory Medical Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464394/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012548
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki